FDA Inspection
Transdermal Therapeutics Inc.Transdermal Therapeutics Inc. – FDA Inspection, Jun 27, 2014
Record Details
This FDA Inspection record concerns Transdermal Therapeutics Inc., with an inspection on June 27, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 27, 2014
- Product Type
- Drugs
View Company Profile
ID · fb0e7469-4ca5-43ce-841b-e117f8aad425
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 887493
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
8- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
- 21 CFR 211.170(b)Reserve samples identified, representative, stored
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.198(a)Complaints reviewed by Quality Control Unit
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.